Voloridge Investment Management, LLC Blueprint Medicines Corp Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 287,560 shares of BPMC stock, worth $26 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

287,560

Previous 226,580 26.91%

Holding current value

$26 Million

Previous $24.4 Million 8.87%

% of portfolio

0.1%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $5.13 Million - $7.35 Million	60,980 Added 26.91%	287,560 $26.6 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $693,705 - $885,904	8,144 Added 3.73%	226,580 $24.4 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $5.67 Million - $7.73 Million	77,447 Added 54.93%	218,436 $20.7 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $6.2 Million - $13.1 Million	140,989 New	140,989 $13 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $1.57 Million - $2.07 Million	41,352 New	41,352 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $859,045 - $1.34 Million	-17,205 Reduced 29.6%	40,927 $2.7 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $2.63 Million - $4.08 Million	58,132 New	58,132 $2.94 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $2.13 Million - $2.88 Million	-26,268 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $554,046 - $675,993	6,693 Added 34.19%	26,268 $2.31 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $9.12 Million - $10.9 Million	-100,529 Reduced 83.7%	19,575 $1.9 Million
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $9.44 Million - $12.8 Million	102,554 Added 584.35%	120,104 $13.5 Million
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $1.17 Million - $1.63 Million	17,550 New	17,550 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $254,278 - $353,068	-4,454 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $405,471 - $692,950	-8,428 Reduced 65.42%	4,454 $260,000
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $859,615 - $1.06 Million	12,882 New	12,882 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $1.71 Million - $2.38 Million	-23,450 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $1.72 Million - $2.29 Million	23,450 New	23,450 $2.21 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Blueprint Medicines Corp Transaction History